Results 241 to 250 of about 49,741 (289)

Five‐Year Effectiveness and Renal Safety Following Switching to Tenofovir Alafenamide in Chronic Hepatitis B Patients With Renal Impairment

Journal of Gastroenterology and Hepatology, Volume 40, Issue 10, Page 2560-2567, October 2025.
ABSTRACT Background and Aim Long‐term nucleos(t)ide analog (NUC) therapy is essential for chronic hepatitis B (CHB) management. However, data on long‐term outcomes, particularly for patients switching to tenofovir alafenamide (TAF) and patients with chronic kidney disease (CKD), remain limited.
Eiichi Ogawa, Motoyuki Kohjima, Toshimasa Koyanagi, Kazufumi Dohmen, Aritsune Ooho, Akira Kawano, Norihiro Furusyo, Eiji Kajiwara, Takeaki Satoh, Kazuhiro Takahashi, Koichi Azuma, Rie Sugimoto, Yasunori Ichiki, Takeshi Senju, Hiromasa Amagase, Masatake Tanaka, Makoto Nakamuta, Hideyuki Nomura, Jun Hayashi, The Kyushu University Liver Disease Study (KULDS) Group   +19 more
wiley   +1 more source

Prognostic value of combined detection of alpha-fetoprotein, plasma prothrombin activity, and serum prealbumin in acute-on-chronic liver failure. [PDF]

World J Gastrointest Surg
Duan RX, Liu L, Wang Y, Wu WM.
europepmc   +1 more source

Liver Stiffness Measurements After Oral Antivirals Effectively Predict the Risk of HCC in Patients With Chronic Hepatitis C

Journal of Gastroenterology and Hepatology, Volume 40, Issue 10, Page 2568-2579, October 2025.
ABSTRACT Objective Hepatocellular carcinoma (HCC) can still occur in patients with chronic hepatitis C after achieving a sustained virologic response (SVR) with direct‐acting antiviral (DAA) therapy. Therefore, we aimed to identify and validate predictors and HCC risk models using longitudinal data.
Yu Rim Lee, Hyun Young Woo, Young Oh. Kweon, Won Young Tak, Se Young Jang, Jung Gil Park, Min Kyu Kang, Jeong Eun Song, Byoung Kuk Jang, Changhyeong Lee, Byung Seok Kim, Jae Seok Hwang, Woo Jin Chung, Jeong Heo, Nae‐Yun Heo, Seung Ha Park, Jun Sik Yoon, Joonho Jeong, Sang Gyu Kwak, Yeowool Kang, Yang Hyun Baek, Soo Young Park   +21 more
wiley   +1 more source

Analysis of the optimal patterns of serum alpha fetoprotein (AFP), AFP-L3% and protein induced by vitamin K absence or antagonist-II (PIVKA-II) detection in the diagnosis of liver cancers. [PDF]

PeerJ
Luo L, Wang X, Peng X, Zhong R, Xuan X, Lin H, Lin X, Duan C.   +7 more
europepmc   +1 more source

Hypertension as an Adverse Event Potentially Impacting the Therapeutic Efficacy of Atezolizumab Plus Bevacizumab in Patients With Unresectable Hepatocellular Carcinoma

Journal of Gastroenterology and Hepatology, Volume 40, Issue 10, Page 2580-2590, October 2025.
ABSTRACT Background and Aim Atezolizumab plus bevacizumab is used as a first‐line treatment for unresectable hepatocellular carcinoma (uHCC). However, the relationship between its adverse events (AEs) and treatment efficacy remains unclear. In this study, we aimed to clarify this association.
Kazuki Maesaka, Hayato Hikita, Machiko Kai, Yuki Tahata, Kumiko Shirai, Akira Doi, Kazuhiro Murai, Yoshinobu Saito, Ryoko Yamada, Takahiro Kodama, Kazuyoshi Ohkawa, Masanori Miyazaki, Hisashi Ishida, Kengo Matsumoto, Yasutoshi Nozaki, Takayuki Yakushijin, Ryotaro Sakamori, Nobuyuki Tatsumi, Sadaharu Iio, Takatoshi Nawa, Naruyasu Kakita, Masanori Nakahara, Atsushi Hosui, Takeo Usui, Kazuho Imanaka, Yoshinori Doi, Mitsuru Sakakibara, Yuichi Yoshida, Tomohide Tatsumi, Tetsuo Takehara   +29 more
wiley   +1 more source

Combined Analysis of Protein Induced by Prothrombin Induced by Vitamin K Absence (PIVKA) and Alpha-L-Fucosidase (AFU) with Alpha-Fetoprotein (AFP) May Improve the Diagnostic Efficacy for Liver Cirrhosis and Hepatocellular Carcinoma in Chronic Hepatitis B. [PDF]

Int J Gen Med
Hou H, Weng R, Liang L, Han W.
europepmc   +1 more source

Changes in alpha-fetoprotein across the systemic therapy continuum in advanced hepatocellular carcinoma-a real-world, multicenter study. [PDF]

Ther Adv Med Oncol
Li M, Hannan LM, Goyal L, Bocobo AG, Parks AL, Bauer K, Baiev I, Dinicola C, Gordan JD, Venook AP, Harris WP, Bracci P, Kelley RK.   +12 more
europepmc   +1 more source

Highly sensitive detection of alpha-fetoprotein using sandwich sensors. [PDF]

RSC Adv
Xie B, Wang H, Mochiwa ZO, Zhou D, Gao L.   +4 more
europepmc   +1 more source

High Plasma Alpha-Fetoprotein Level Is Associated With Early Postoperative Complications in Patients With Hepatocellular Carcinoma in Southern Vietnam During 2018-2023: A Cross-Sectional Study. [PDF]

Health Sci Rep
Thanh LH, Manh KN, Quang HN.
europepmc   +1 more source